BU-NOT-SET

CONTACT US
Overcoming the challenges surrounding manufacturing oncolytic viruses
  • Biologics
Virus
Insight
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
  • Drug product
  • Industry trends
DCAT insights
Insight
Developing a robust dissolution method for low-dose formulations
  • Analytical chemistry
  • Drug product
low-dose formulation
White paper
Sustainability report 2022
  • Sustainability
Sustainability report 2022
Report
Navigating the changing oral solid dose landscape
  • Drug product
  • Industry trends
Oral solid dose
Insight
The opportunities and obstacles of filling and packaging pre-filled syringes
  • Drug product
  • Manufacturing
pre-filled syringes
Insight
Tips for facilitating a successful tech transfer between sponsor and CDMO
  • Drug product
  • Industry trends
Tech transfer
Insight
Alternative drug delivery formulation & device expertise
  • Drug product
  • Industry trends
Industry trends
Insight
The 3 key trends shaping the CDMO industry in 2023 and beyond
  • Industry trends
CDMO trends
Insight
Insight
  • Biologics
Unlocking the potential of RNA therapeutics through innovation and collaboration
White paper
  • Analytical chemistry
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach